Dr. Alyn Louise Adrain, MD

Dr. Adrain practices at West River Endoscopy in Providence, Rhode Island.

Dr. Adrain's NPI, 1225027766, was assigned on October 18, 2005. Dr. Adrain graduated from The Warren Alpert Medical School of Brown University in 1988. Dr. Adrain holds Rhode Island license 10330.

Dr. Adrain's primary practice is West River Endoscopy, at 44 West River Street, Providence, RI 02904. The practice phone is (401) 274-4800.

Dr. Adrain's primary practice is West River Endoscopy in Providence, Rhode Island. Dr. Adrain is also affiliated with The Miriam Hospital. The medical group on file is University Gastroenterology. Dmand AI also links Dr. Adrain to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adrain practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Adrain's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Adrain is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Adrain's licenses on file in 3 states: Rhode Island, New York and Pennsylvania.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Adrain treats.

CMS data shows 562 Medicare services from Dr. Adrain across 12 procedure codes in 2024, for 293 Medicare patients. Medicare paid $44,844 for them.

CMS counts 293 Medicare patients who saw Dr. Adrain in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Adrain's median patient age at 66, with 81% women.

In 2024, Dr. Adrain wrote 1,744 Medicare Part D claims for 549 patients. 89% of them were for generic drugs. CMS names the drug for 1,612 of them, across 20 drugs with 11 or more claims each, at $112,989 in total drug cost. In 2023, CMS named 1,639 claims across 23 drugs.

Dr. Adrain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 52 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Adrain, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Adrain, published from 2018 to 2019. The most frequent topics are Endosonography, Esophageal and Gastric Varices and Esophagus. Dr. Adrain has published most often in Gastrointest Endosc. Dr. Adrain's most frequent co-authors are Edward Roy Feller, MD, James Allison, MD and Samir Ashok Shah, MD.

CMS Open Payments shows 132 general payments to Dr. Adrain from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $1,405.

Dmand AI lists 5 awards for Dr. Adrain, most recently CMS Stage 1 EHR in 2013.

Dr. Adrain graduated from The Warren Alpert Medical School of Brown University in 1988. Dr. Adrain is a member of ACG, ACP, AGA, AMA and ASGE.

Dr. Adrain is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.